Table 4 Baseline characteristic of patients in the low and high Apo B/A1 ratio groups
Characteristics | Low ratio (n = 160) | High ratio (n = 160) | P value |
|---|---|---|---|
Male, n (%) | 110 (68.8%) | 139 (86.9%) |  < 0.001 |
Age, years, mean ± SD | 61.87 ± 10.10 | 57.54 ± 10.38 |  < 0.001 |
Medical history, n (%) | |||
 Atrial fibrillation | 7 (4.4%) | 4 (2.5%) | 0.357 |
 Hypertension | 91 (56.9%) | 75 (46.9%) | 0.073 |
 Diabetes mellitus | 51 (31.9%) | 29 (18.1%) | 0.005 |
 ASCVD | 78 (48.8%) | 70 (43.8%) | 0.370 |
 Prior PCI | 33 (20.6%) | 32 (20.0%) | 0.889 |
 Stroke | 10 (6.3%) | 9 (5.6%) | 0.813 |
Laboratory results, mean ± SD | |||
 HbA1c, % | 6.42 ± 1.59 | 6.54 ± 1.80 | 0.530 |
 NT-proBNP, pg/ml | 607.48 ± 1671.90 | 734.63 ± 2124.78 | 0.556 |
 Hs-cTnI, pg/ml | 249.97 ± 1060.65 | 333.98 ± 890.54 | 0.454 |
 TC, mmol/L | 3.28 ± 0.76 | 4.30 ± 0.92 |  < 0.001 |
 TG, mmol/L | 1.37 ± 0.68 | 2.04 ± 1.71 |  < 0.001 |
 HDL-C, mmol/L | 1.15 ± 0.27 | 0.96 ± 0.20 |  < 0.001 |
 LDL-C, mmol/L | 1.72 ± 0.62 | 2.73 ± 0.72 |  < 0.001 |
 VLDL-C, mmol/L | 0.42 ± 0.26 | 0.62 ± 0.60 |  < 0.001 |
 Lipoprotein (a), mg/dl | 19.56 ± 24.56 | 26.85 ± 31.42 | 0.022 |
 LVEF, % | 63.12 ± 7.17 | 62.52 ± 8.40 | 0.529 |
Plaque morphology, n (%) | Â | Â | Â |
 Plaque rupture | 27 (16.9) | 52 (32.5%) | 0.001 |
 Plaque erosion | 12 (7.5%) | 31 (19.4%) | 0.002 |
 Calcified nodule | 7 (4.4%) | 5 (3.1%) | 0.556 |
Thrombus | 30 (18.8%) | 59 (36.9%) |  < 0.001 |
 TCFA | 6 (3.8%) | 10 (6.3%) | 0.305 |
 Fibrous plaque | 64 (40.0%) | 73 (45.6%) | 0.309 |
  FCT, μm | 955.02 ± 347.42 | 966.28 ± 303.87 | 0.844 |
 Calcification | 56 (35.0%) | 30 (18.8%) | 0.001 |
  Angle, ° | 171.09 ± 122.51 | 208.65 ± 95.80 | 0.142 |
  Thickness, mm | 0.82 ± 0.27 | 0.89 ± 0.33 | 0.310 |
  Length, mm | 22.30 ± 11.18 | 24.48 ± 14.02 | 0.489 |
 Lipid-rich plaque | 39 (24.4%) | 40 (25.0%) | 0.897 |
  FCT, μm | 181.46 ± 154.11 | 114.98 ± 80.11 | 0.020 |
  Lipid arc, ° | 191.38 ± 72.15 | 186.40 ± 61.03 | 0.741 |
 Cholesterol crystal | 64 (40.0%) | 73 (45.6%) | 0.309 |
 Micro-vessel | 32 (20.0%) | 37 (23.1%) | 0.497 |
 Macrophage | 34 (21.3%) | 27 (16.9%) | 0.319 |
Stents, n (%) | |||
 0 | 56 (35.0%) | 39 (24.4%) |  |
 1 | 57 (35.6%) | 67 (41.9%) |  |
 2 | 29 (18.1%) | 38 (23.8%) |  |
 3 | 11 (6.9%) | 10 (6.3%) |  |
  > 3 | 7 (4.4%) | 6 (3.8%) |  |
Statins, n (%) | 98 (61.3%) | 110 (68.8%) | 0.160 |